Wall Street brokerages predict that Surgery Partners, Inc. (NASDAQ:SGRY) will report $0.06 earnings per share for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for Surgery Partners’ earnings, with the highest EPS estimate coming in at $0.13 and the lowest estimate coming in at $0.01. Surgery Partners posted earnings per share of $0.19 in the same quarter last year, which suggests a negative year over year growth rate of 68.4%. The firm is scheduled to report its next earnings results on Thursday, March 8th.

On average, analysts expect that Surgery Partners will report full year earnings of $0.06 per share for the current fiscal year, with EPS estimates ranging from $0.01 to $0.13. For the next year, analysts anticipate that the firm will post earnings of $0.27 per share, with EPS estimates ranging from $0.05 to $0.57. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that cover Surgery Partners.

A number of brokerages recently weighed in on SGRY. Jefferies Group reiterated a “buy” rating and set a $16.00 price target (down previously from $22.00) on shares of Surgery Partners in a research note on Friday, September 8th. KeyCorp reiterated a “hold” rating on shares of Surgery Partners in a research note on Friday, September 22nd. Bank of America decreased their price target on shares of Surgery Partners from $23.00 to $19.00 and set a “buy” rating for the company in a research note on Monday, October 9th. Zacks Investment Research upgraded shares of Surgery Partners from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 11th. Finally, ValuEngine cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Thursday, November 9th. Four equities research analysts have rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $18.57.

Several institutional investors and hedge funds have recently made changes to their positions in SGRY. Bain Capital Investors LLC purchased a new position in shares of Surgery Partners in the 3rd quarter valued at about $273,816,000. Elk Creek Partners LLC purchased a new position in shares of Surgery Partners in the 2nd quarter valued at about $9,888,000. Royce & Associates LP increased its holdings in Surgery Partners by 160.0% during the 3rd quarter. Royce & Associates LP now owns 681,582 shares of the company’s stock valued at $7,054,000 after acquiring an additional 419,457 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Surgery Partners by 156.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 524,775 shares of the company’s stock valued at $5,379,000 after acquiring an additional 319,775 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in Surgery Partners by 119.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 305,909 shares of the company’s stock valued at $3,166,000 after acquiring an additional 166,590 shares in the last quarter. Institutional investors and hedge funds own 94.16% of the company’s stock.

Shares of Surgery Partners (NASDAQ:SGRY) traded up $0.25 during trading hours on Friday, hitting $9.75. 285,700 shares of the company’s stock were exchanged, compared to its average volume of 333,539. Surgery Partners has a 52 week low of $7.10 and a 52 week high of $24.05. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.92 and a current ratio of 2.09. The stock has a market cap of $516.95 and a P/E ratio of 63.33.

TRADEMARK VIOLATION WARNING: This report was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/12/15/zacks-brokerages-expect-surgery-partners-inc-sgry-will-announce-earnings-of-0-06-per-share.html.

Surgery Partners Company Profile

Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.

Get a free copy of the Zacks research report on Surgery Partners (SGRY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Surgery Partners (NASDAQ:SGRY)

Receive News & Stock Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related stocks with our FREE daily email newsletter.